A METHOD OF MODULATING CELLULAR ACTIVITY AND MOLECULES FOR USE THEREIN

Details for Australian Patent Application No. 2003257263 (hide)

Owner MONASH UNIVERSITY

Inventors Webb, Andrew; Purcell, Anthony; Perlmutter, Patrick; Aguilar, Marie-Isabel; Rossjohn, Jamie

Agent Davies Collison Cave

Pub. Number AU-A-2003257263

PCT Number PCT/AU03/01150

PCT Pub. Number WO2004/022084

Priority 2002951212 04.09.02 AU

Filing date 4 September 2003

Wipo publication date 29 March 2004

International Classifications

A61K 038/04 Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 039/00 Medicinal preparations containing antigens or antibodies

A61P 037/02 Drugs for immunological or allergic disorders

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 2002951212 04.09.02 AU

13 May 2004 Application Open to Public Inspection

  Published as AU-A-2003257263

2 March 2006 Assignment before Grant

  Monash University; University of Melbourne The application has been assigned to Monash University

18 May 2006 Assignment before Grant

  Monash University The application has been assigned to Monash University; Cancer Therapeutics Limited

10 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003257264-Repair of DNA mutagenic damage

2003257262-PEPTIDOMIMETIC DRUGS